Infection Control Market - Global Forecast 2025-2032

The Infection Control Market is experiencing a period of accelerated transformation, driven by innovation in technology, evolving care protocols, and increased focus on integrated safety across healthcare and industrial environments. Senior stakeholders are re-examining strategies to address persistent and emerging challenges in contamination prevention, regulatory compliance, and operational continuity.

Market Snapshot: Infection Control Market Size and Growth Outlook

The infection control market grew from USD 50.34 billion in 2024 to USD 53.48 billion in 2025. It is expected to continue growing at a CAGR of 6.63%, reaching USD 84.14 billion by 2032.

Scope & Segmentation

• Product Type: Air purifiers (including HEPA filters, ionizers, UV air purifiers), disinfectants & antiseptics (alcohol, chlorine, hydrogen peroxide, quaternary ammonium compounds), hand hygiene products (foam sanitizers, gel sanitizers, soap, wipes), infection monitoring systems (incubator-based, rapid test kits), instrument disinfectors (automated endoscope reprocessors, washer disinfectors), sterilization equipment (autoclaves, EO, radiation, UV sterilizers), and surface disinfectants.
• Technology: AI & IoT, chemical sterilization (ethylene oxide, hydrogen peroxide plasma, ozone, peracetic acid), filtration technology (HEPA filters, membrane filtration), nanotechnology-based disinfectants, physical sterilization (dry heat, radiation, steam), and ultraviolet (UV) disinfection.
• Application: Biomedical waste management, disinfection & sterilization (covering air, hand hygiene, device, surface, textiles, instruments), endoscope reprocessing, and infection surveillance systems.
• Distribution Channel: Offline and online.
• End User: Ambulatory centers, clinics (including dental and specialty), food & beverage processing, hospitals, pharmaceutical & biotech, and research laboratories.
• Regions: Americas (United States, Canada, Mexico, Brazil, Argentina, Chile, Colombia, Peru), Europe, Middle East, Africa (UK, Germany, France, Russia, Italy, Spain, Netherlands, Sweden, Poland, Switzerland, UAE, Saudi Arabia, Qatar, Turkey, Israel, South Africa, Nigeria, Egypt, Kenya), and Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Malaysia, Singapore, Taiwan).
• Company Coverage: Leading businesses including 3M Company, Abbott Laboratories, Becton, Dickinson and Company, Ecolab Corporation, STERIS Corporation, and others.

Key Takeaways for Senior Decision-Makers

• Evolving pathogen threats and stricter regulatory standards have prompted rapid adoption of advanced air purification, sterilization, and monitoring technologies across healthcare and manufacturing settings.
• Shifts in value-based care require health systems to demonstrate measurable infection prevention outcomes, linking quality to reimbursement and investment strategies.
• Integrated digital platforms—featuring predictive analytics and automated systems—are facilitating real-time risk assessment, operational efficiency, and improved compliance tracking.
• Regional variations in infrastructure and regulatory alignment create differentiated opportunities for solution customization and technology transfer.
• Strategic alignment of procurement with sustainability goals is steering the market toward green chemistries and energy-efficient equipment designs.
• Continued innovation in diagnostic kits and AI-powered surveillance stands out as a key driver of competitive advantage.

Tariff Impact: Navigating Regulatory Adjustments in Equipment Supply Chains

Recent changes in import duties on infection control equipment are influencing global and regional supply chain strategies. Manufacturers and procurement teams are diversifying supplier bases, investing in localized production, and renegotiating contracts to ensure pricing stability and supply reliability. Efforts to near-shore production and foster regional partnerships are strengthening risk resilience and helping businesses adapt to fluctuating cost pressures and regulatory shifts.

Methodology & Data Sources

This report applies a mixed-methods framework, combining primary interviews with infection prevention and supply chain experts and secondary analysis from journals, regulatory filings, and technical papers. Data integrity was maintained through consistency validation, cross-verification, and thorough peer review.

Why This Report Matters

• Provides actionable intelligence for leaders seeking to benchmark, invest, and innovate in line with next-generation infection control trends.
• Equips organizations to optimize procurement strategies, align with evolving quality mandates, and mitigate supply chain risks amid market shifts.
• Supports the integration of sustainable practices with operational and compliance objectives across diverse care and industrial settings.

Conclusion

The infection control market’s future hinges on innovation, customization, and cross-disciplinary collaboration. Robust segment analysis and strategic guidance in this report empower decision-makers to respond to complexity with clarity and agility.

Additional Product Information:

• Purchase of this report includes 1 year online access with quarterly updates.
• This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.